Page last updated: 2024-11-05

2-benzylpyridine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-Benzylpyridine is a heterocyclic compound that has been studied for its potential applications in various fields. It has been reported as a precursor for the synthesis of biologically active compounds, including pharmaceuticals and agrochemicals. Notably, it has been used in the preparation of potent inhibitors of acetylcholinesterase, an enzyme associated with Alzheimer's disease. Furthermore, 2-benzylpyridine has shown promise as a ligand for metal complexes, with potential applications in catalysis and materials science. Its versatility and intriguing properties make it an attractive target for further research and development.'

2-benzylpyridine: an inducer of hepatic microsomal cytochrome P450 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID7581
CHEMBL ID3248606
SCHEMBL ID64435
MeSH IDM0202101

Synonyms (41)

Synonym
AC-19013
2-benzyl-pyridine
pyridine, 2-benzyl-
nsc4033
pyridine, 2-(phenylmethyl)-
nsc-4033
101-82-6
2-benzylpyridine
AC-907/25014395
brn 0115875
nsc 4033
2-(phenylmethyl)pyridine
ai3-11559
einecs 202-979-1
inchi=1/c12h11n/c1-2-6-11(7-3-1)10-12-8-4-5-9-13-12/h1-9h,10h
2-benzylpyridine, 98%
B0436
AKOS000119194
A800462
BBL011348
STL146438
ew2n4v60mq ,
unii-ew2n4v60mq
5-20-07-00556 (beilstein handbook reference)
FT-0611322
pheniramine maleate impurity a [ep impurity]
CHEMBL3248606
SCHEMBL64435
AM81314
DTXSID5059240
benzylpyridine
W-108900
mfcd00006352
AS-59231
pheniramine impurity a, european pharmacopoeia (ep) reference standard
Z57160157
pheniramine maleate imp. a (ep); pheniramine imp. a (ep); 2-benzylpyridine; pheniramine maleate impurity a; pheniramine impurity a
F0001-0053
F19573
Q27277389
EN300-18087
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (8)

Assay IDTitleYearJournalArticle
AID1132258Drug recovery in hydrolyzed fraction of Sprague-Dawley rat serum treated with 1-(3-Chlorophenyl)-1-methyl-2-phenyl-2-(2-pyridine)ethanol at 25 mg/kg, ip after 72 hrs by RP-HPLC analysis1978Journal of medicinal chemistry, Feb, Volume: 21, Issue:2
Dehydrative metabolites of 1-(3-chlorophenyl)-1methyl-2-phenyl-2-(2-pyridine)ethanol as potential hypocholesteremic agents.
AID1132260Drug recovery in sephadex G-10 chromatographic fraction of Sprague-Dawley rat urine treated with 1-(3-Chlorophenyl)-1-methyl-2-phenyl-2-(2-pyridine)ethanol at 25 mg/kg, ip by RP-HPLC analysis1978Journal of medicinal chemistry, Feb, Volume: 21, Issue:2
Dehydrative metabolites of 1-(3-chlorophenyl)-1methyl-2-phenyl-2-(2-pyridine)ethanol as potential hypocholesteremic agents.
AID1132256Drug recovery in Sprague-Dawley rat serum treated with 1-(3-Chlorophenyl)-1-methyl-2-phenyl-2-(2-pyridine)ethanol at 25 mg/kg, ip after 10 hrs by RP-HPLC analysis1978Journal of medicinal chemistry, Feb, Volume: 21, Issue:2
Dehydrative metabolites of 1-(3-chlorophenyl)-1methyl-2-phenyl-2-(2-pyridine)ethanol as potential hypocholesteremic agents.
AID1149238Dissociation constant, pKa of the compound1976Journal of medicinal chemistry, Apr, Volume: 19, Issue:4
Mode of action and quantitative structure-activity correlations of tuberculostatic drugs of the isonicotinic acid hydrazide type.
AID1132261Drug recovery in pentane extract of Sprague-Dawley rat feces treated with 1-(3-Chlorophenyl)-1-methyl-2-phenyl-2-(2-pyridine)ethanol at 25 mg/kg, ip by RP-HPLC analysis1978Journal of medicinal chemistry, Feb, Volume: 21, Issue:2
Dehydrative metabolites of 1-(3-chlorophenyl)-1methyl-2-phenyl-2-(2-pyridine)ethanol as potential hypocholesteremic agents.
AID1132264Drug recovery in Sprague-Dawley rat serum treated with 1-(3-Chlorophenyl)-1-methyl-2-phenyl-2-(2-pyridine)ethanol at 25 mg/kg, ip after 2 hrs by RP-HPLC analysis1978Journal of medicinal chemistry, Feb, Volume: 21, Issue:2
Dehydrative metabolites of 1-(3-chlorophenyl)-1methyl-2-phenyl-2-(2-pyridine)ethanol as potential hypocholesteremic agents.
AID1132259Drug recovery in pentane extract of Sprague-Dawley rat urine treated with 1-(3-Chlorophenyl)-1-methyl-2-phenyl-2-(2-pyridine)ethanol at 25 mg/kg, ip by RP-HPLC analysis1978Journal of medicinal chemistry, Feb, Volume: 21, Issue:2
Dehydrative metabolites of 1-(3-chlorophenyl)-1methyl-2-phenyl-2-(2-pyridine)ethanol as potential hypocholesteremic agents.
AID1132257Drug recovery in Sprague-Dawley rat serum treated with 1-(3-Chlorophenyl)-1-methyl-2-phenyl-2-(2-pyridine)ethanol at 25 mg/kg, ip after 72 hrs by RP-HPLC analysis1978Journal of medicinal chemistry, Feb, Volume: 21, Issue:2
Dehydrative metabolites of 1-(3-chlorophenyl)-1methyl-2-phenyl-2-(2-pyridine)ethanol as potential hypocholesteremic agents.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (28.57)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's4 (57.14)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 35.97

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index35.97 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.97 (4.65)
Search Engine Demand Index42.07 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (35.97)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]